Mike Matson
Stock Analyst at Needham
(3.36)
# 1,016
Out of 5,044 analysts
543
Total ratings
47%
Success rate
3.55%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PEN Penumbra | Reiterates: Buy | $326 | $240.20 | +35.72% | 12 | Oct 27, 2025 | |
| TMDX TransMedics Group | Upgrades: Buy | $148 | $130.98 | +12.99% | 13 | Oct 23, 2025 | |
| HOLX Hologic | Reiterates: Hold | n/a | $73.97 | - | 22 | Oct 21, 2025 | |
| BSX Boston Scientific | Reiterates: Buy | $121 | $101.45 | +19.27% | 34 | Oct 17, 2025 | |
| INMD InMode | Reiterates: Hold | n/a | $15.26 | - | 21 | Oct 10, 2025 | |
| LIVN LivaNova | Reiterates: Buy | $64 | $53.96 | +18.61% | 27 | Sep 3, 2025 | |
| NEO NeoGenomics | Maintains: Buy | $8 → $14 | $10.15 | +38.00% | 27 | Aug 29, 2025 | |
| AORT Artivion | Maintains: Buy | $45 → $50 | $44.95 | +11.23% | 19 | Aug 22, 2025 | |
| IMDX Insight Molecular Diagnostics | Reiterates: Buy | $4.25 | $6.21 | -31.56% | 1 | Aug 18, 2025 | |
| MDT Medtronic | Reiterates: Hold | n/a | $93.81 | - | 21 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.26 | +139.04% | 21 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $68 | $50.70 | +34.12% | 14 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $49 | $32.84 | +49.21% | 16 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $448 | $378.55 | +18.35% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $45 | $36.49 | +23.32% | 35 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $108 | $82.53 | +30.86% | 30 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $51.85 | -7.43% | 3 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $61 | $47.07 | +29.61% | 25 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $8.53 | +40.68% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $16.93 | +148.08% | 23 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $41 | $35.78 | +14.61% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $27.35 | - | 21 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $147.00 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $9.73 | -28.06% | 20 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $121.05 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $241.14 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $131.21 | - | 9 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $101.52 | - | 26 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $259.79 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $15.57 | +169.75% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $62.98 | +19.09% | 1 | Feb 18, 2021 |
Penumbra
Oct 27, 2025
Reiterates: Buy
Price Target: $326
Current: $240.20
Upside: +35.72%
TransMedics Group
Oct 23, 2025
Upgrades: Buy
Price Target: $148
Current: $130.98
Upside: +12.99%
Hologic
Oct 21, 2025
Reiterates: Hold
Price Target: n/a
Current: $73.97
Upside: -
Boston Scientific
Oct 17, 2025
Reiterates: Buy
Price Target: $121
Current: $101.45
Upside: +19.27%
InMode
Oct 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $15.26
Upside: -
LivaNova
Sep 3, 2025
Reiterates: Buy
Price Target: $64
Current: $53.96
Upside: +18.61%
NeoGenomics
Aug 29, 2025
Maintains: Buy
Price Target: $8 → $14
Current: $10.15
Upside: +38.00%
Artivion
Aug 22, 2025
Maintains: Buy
Price Target: $45 → $50
Current: $44.95
Upside: +11.23%
Insight Molecular Diagnostics
Aug 18, 2025
Reiterates: Buy
Price Target: $4.25
Current: $6.21
Upside: -31.56%
Medtronic
Aug 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $93.81
Upside: -
Aug 13, 2025
Reiterates: Buy
Price Target: $3
Current: $1.26
Upside: +139.04%
Aug 7, 2025
Maintains: Buy
Price Target: $84 → $68
Current: $50.70
Upside: +34.12%
Aug 7, 2025
Maintains: Buy
Price Target: $57 → $49
Current: $32.84
Upside: +49.21%
Aug 1, 2025
Maintains: Buy
Price Target: $442 → $448
Current: $378.55
Upside: +18.35%
Jul 30, 2025
Maintains: Buy
Price Target: $44 → $45
Current: $36.49
Upside: +23.32%
Jul 18, 2025
Reiterates: Buy
Price Target: $108
Current: $82.53
Upside: +30.86%
Jun 13, 2025
Reiterates: Buy
Price Target: $48
Current: $51.85
Upside: -7.43%
Jun 12, 2025
Downgrades: Hold
Price Target: $61
Current: $47.07
Upside: +29.61%
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $8.53
Upside: +40.68%
May 8, 2025
Reiterates: Buy
Price Target: $42
Current: $16.93
Upside: +148.08%
May 8, 2025
Maintains: Buy
Price Target: $51 → $41
Current: $35.78
Upside: +14.61%
Apr 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $27.35
Upside: -
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $147.00
Upside: -
Apr 10, 2025
Reiterates: Buy
Price Target: $7
Current: $9.73
Upside: -28.06%
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $121.05
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $241.14
Upside: -
Mar 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $131.21
Upside: -
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $101.52
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $259.79
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $15.57
Upside: +169.75%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $62.98
Upside: +19.09%